IL128786A0 - Use of benzopyranols to treat neurological disorders - Google Patents
Use of benzopyranols to treat neurological disordersInfo
- Publication number
- IL128786A0 IL128786A0 IL12878697A IL12878697A IL128786A0 IL 128786 A0 IL128786 A0 IL 128786A0 IL 12878697 A IL12878697 A IL 12878697A IL 12878697 A IL12878697 A IL 12878697A IL 128786 A0 IL128786 A0 IL 128786A0
- Authority
- IL
- Israel
- Prior art keywords
- benzopyranols
- neurological disorders
- treat neurological
- treat
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
| PCT/EP1997/005168 WO1998011890A1 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL128786A0 true IL128786A0 (en) | 2000-01-31 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12878697A IL128786A0 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (xx) |
| JP (1) | JP2001500520A (xx) |
| KR (1) | KR20000036184A (xx) |
| CN (1) | CN1230885A (xx) |
| AP (1) | AP9901473A0 (xx) |
| AR (1) | AR008838A1 (xx) |
| AT (1) | ATE270102T1 (xx) |
| AU (1) | AU730465B2 (xx) |
| BG (1) | BG103252A (xx) |
| BR (1) | BR9712030A (xx) |
| CA (1) | CA2266681A1 (xx) |
| DE (1) | DE69729735T2 (xx) |
| DZ (1) | DZ2311A1 (xx) |
| EA (1) | EA199900306A1 (xx) |
| ES (1) | ES2223075T3 (xx) |
| GB (1) | GB9619492D0 (xx) |
| HU (1) | HUP9904638A3 (xx) |
| ID (2) | ID23175A (xx) |
| IL (1) | IL128786A0 (xx) |
| MA (1) | MA24321A1 (xx) |
| NO (1) | NO991292D0 (xx) |
| NZ (1) | NZ334271A (xx) |
| OA (1) | OA10998A (xx) |
| PE (1) | PE109898A1 (xx) |
| PL (1) | PL332313A1 (xx) |
| SK (1) | SK35199A3 (xx) |
| TR (1) | TR199900527T2 (xx) |
| UY (1) | UY24717A1 (xx) |
| WO (1) | WO1998011890A1 (xx) |
| ZA (1) | ZA978359B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| MX2010013312A (es) * | 2008-06-05 | 2011-05-30 | Minster Res Ltd | Tratamientos novedoos. |
| MX2010013313A (es) * | 2008-06-05 | 2011-05-30 | Minster Res Ltd | Tratamientos novedosos. |
| US8952034B2 (en) | 2009-07-27 | 2015-02-10 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| MX2012006353A (es) * | 2009-12-03 | 2012-06-27 | Proximagen Ltd | Tratamiento de enfermedades infecciosas. |
| US20130018091A1 (en) * | 2009-12-03 | 2013-01-17 | Peter Blower | Treatment of allodynia and hyperalgesia |
| NZ604478A (en) | 2010-07-02 | 2014-12-24 | Gilead Sciences Inc | Fused heterocyclic compounds as ion channel modulators |
| MX361350B (es) | 2011-05-10 | 2018-12-04 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores del canal de sodio. |
| NO3175985T3 (xx) | 2011-07-01 | 2018-04-28 | ||
| TW201837023A (zh) | 2011-07-01 | 2018-10-16 | 美商基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
| CA2192480C (en) * | 1994-06-10 | 2007-07-24 | Wai Ngor Chan | Benzopyrans and their use as therapeutic agents |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Application Discontinuation
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Application Discontinuation
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 EP EP97909300A patent/EP0939630B1/en not_active Expired - Lifetime
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292D0/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69729735T2 (de) | 2005-07-14 |
| EA199900306A1 (ru) | 1999-08-26 |
| CA2266681A1 (en) | 1998-03-26 |
| MA24321A1 (fr) | 1998-04-01 |
| CN1230885A (zh) | 1999-10-06 |
| NZ334271A (en) | 2001-03-30 |
| ATE270102T1 (de) | 2004-07-15 |
| GB9619492D0 (en) | 1996-10-30 |
| ZA978359B (en) | 1999-03-17 |
| NO991292L (no) | 1999-03-17 |
| NO991292D0 (no) | 1999-03-17 |
| PL332313A1 (en) | 1999-08-30 |
| KR20000036184A (ko) | 2000-06-26 |
| SK35199A3 (en) | 2000-07-11 |
| ID19542A (id) | 1998-07-23 |
| UY24717A1 (es) | 2001-08-27 |
| WO1998011890A1 (en) | 1998-03-26 |
| ES2223075T3 (es) | 2005-02-16 |
| JP2001500520A (ja) | 2001-01-16 |
| AR008838A1 (es) | 2000-02-23 |
| OA10998A (en) | 2003-03-04 |
| DE69729735D1 (de) | 2004-08-05 |
| PE109898A1 (es) | 1999-03-21 |
| DZ2311A1 (fr) | 2002-12-28 |
| BR9712030A (pt) | 1999-08-24 |
| EP0939630B1 (en) | 2004-06-30 |
| AU4704797A (en) | 1998-04-14 |
| BG103252A (en) | 1999-09-30 |
| HUP9904638A2 (hu) | 2001-05-28 |
| AP9901473A0 (en) | 1999-03-31 |
| EP0939630A1 (en) | 1999-09-08 |
| ID23175A (id) | 2000-03-23 |
| TR199900527T2 (xx) | 1999-06-21 |
| HUP9904638A3 (en) | 2001-08-28 |
| AU730465B2 (en) | 2001-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
| IL133800A0 (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | |
| HRP20000201B1 (en) | Prostaglandin agonists and their use to treat bone disorders | |
| PL339425A1 (en) | Treatment of behavioural disorders | |
| EP1063990A4 (en) | THERAPY FOR ESTROGEN RELATED DISORDERS | |
| ZA969520B (en) | Use of epinastine for the treatment of pain | |
| IL141263A0 (en) | Methods for treatment of neurological disorders | |
| GB9908175D0 (en) | Method of treating neurological disorders | |
| ZA958725B (en) | Treatment of disorders with duloxetine | |
| AU2058697A (en) | Treatment of sleep disorders | |
| IL128786A0 (en) | Use of benzopyranols to treat neurological disorders | |
| AU1578295A (en) | Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders | |
| HUP0102923A3 (en) | Aza-heterocyclic compounds used to treat neurological disorders and hair loss and pharmaceutical compositions containing them | |
| PL345110A1 (en) | Aza-heterocyclic compounds used to treat neurological disorders and hair loss | |
| GB9926968D0 (en) | Treatment of neurological disorders | |
| IL131347A0 (en) | Treatment of skin disorders | |
| GB9518887D0 (en) | Treatment of muscular disorders | |
| IL140540A0 (en) | Treatment of anxiety disorders | |
| EP0866716A4 (en) | METHODS OF TREATING DISORDERS IN NON-VISUAL SENSORY EPITHELIUMS | |
| HUP9902167A3 (en) | Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system | |
| ZA9610134B (en) | The use of 1-hydroxy-2-pyridones for the treatment of mucosal disorders which are difficult to treat | |
| ZA985818B (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. | |
| GB9613362D0 (en) | Treatment of neurological and psychiatric disorders | |
| AUPO504297A0 (en) | Treatment of neurological disorders | |
| GB9413556D0 (en) | The treatment of neurological and psychiatric disorders |